More than one-fifth of patients with ACI do not have an indication for statins, and statin overuse in these patients could annually lead to over 5600 adverse events each year in the United States, including diabetes, myopathy, and eye disease. These findings emphasize the importance of adhering to guideline indications for the start of statin therapy in ACI.
Keyphrases
- cardiovascular disease
- systematic review
- cerebral ischemia
- end stage renal disease
- coronary artery disease
- subarachnoid hemorrhage
- type diabetes
- newly diagnosed
- ejection fraction
- chronic kidney disease
- brain injury
- peritoneal dialysis
- meta analyses
- metabolic syndrome
- glycemic control
- randomized controlled trial
- adipose tissue
- patient reported outcomes
- risk factors
- insulin resistance
- skeletal muscle
- muscular dystrophy
- smoking cessation